BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Samsung Biologics Delivers KRW 1.3 Trillion Revenue in Q1 2025, Boosted by Plant 5 Launch and Expanding CDMO Contracts

Recorded Q1'25 consolidated revenue of KRW 1.3 trillion Recorded Q1'25 consolidated operating profit of KRW 486.7 billion Company expected to...

April 23, 2025 | News

GC Cell Secures Exclusive Rights to DAAN Biotherapeutics’ Tumor Antigen-Specific Antibody for CAR-T and CAR-NK Therapies

DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusi...

April 22, 2025 | News

Darnatein Secures First International Patent in China for AI-Engineered Osteoarthritis Drug Technology

Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international pat...

April 10, 2025 | News

Seegene to Introduce Vision for Fully Automated PCR Testing with CURECA™ at ESCMID Global 2025 in Vienna

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected ...

April 10, 2025 | News

Lunit Study Reveals Trust Gap Between Radiologists and AI in Real-World Breast Cancer Screening in Sweden

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study i...

April 10, 2025 | Report

GC Biopharma and KDCA Secure MFDS Approval for Korea’s First Recombinant Anthrax Vaccine, BARYTHRAX

GC Biopharma announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by...

April 10, 2025 | News

ABL Bio and GSK Sign Multi-Program Licensing Deal to Develop Neurodegenerative Therapies Using Grabody-B Platform

ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL...

April 07, 2025 | News

Lunit Collaborates with U.S. National Cancer Institute to Advance AI-Driven Cancer Research

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a collaboration with the Nationa...

April 01, 2025 | News

Hyundai ADM Bio Penetrium Shows Strong Anti Metastatic Efficacy in TNBC Study

Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class pseudo-resistance-targeting agent, PenetriumTM, showed significan...

March 28, 2025 | News

LISCure Biosciences Secures World’s First Regulatory Approval for Hair Health Probiotic, Mobiome®, in South Korea

LISCure Biosciences Inc. ("LISCure") announced on the 2025 Feb that it has received approval from the Korean Ministry of Food and Drug Safety (KM...

March 21, 2025 | News

Alamar Biosciences Expands APAC Presence with Five New Distribution Partnerships

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new dis...

March 20, 2025 | News

Bloomage Secures MFDS GMP Certification, Strengthening Pharmaceutical Supply in South Korea

Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection by South Ko...

March 19, 2025 | News

Vatech and Pearl Partner to Elevate Dental AI Diagnostics with Seamless Integration

Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at tra...

March 19, 2025 | News

Stay Connected